EVOKE PHARMA INC - COM (EVOK)

CUSIP: 30049G104

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
404,253
Share change
-190
Total reported value
$2,410,000
Price per share
$5.90
Number of holders
11
Value change
+$35,484
Number of buys
5
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 30049G104?
CUSIP 30049G104 identifies EVOK - EVOKE PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVOKE PHARMA INC - COM (EVOK) as of Q4 2014

As of 31 Dec 2014, EVOKE PHARMA INC - COM (EVOK) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 404,253 shares. The largest 10 holders included Opaleye Management Inc., VANGUARD GROUP INC, CAM Group Holding A/S, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, BlackRock Investment Management, LLC, UBS Group AG, and DEUTSCHE BANK AG\. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.